Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 425 of 506 entries
View as:

Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00008151 Org: User:
Start: 10/31/00 End: 07/31/02 Due: 07/31/03

Health SMART (Stress Management and Relaxation Training) to Improve Vaccine Immune Response

Phase: N/A Priority: Normal
NCT ID: NCT00121160 Org: User:
Start: 09/30/05 End: 07/31/10 Due: 07/31/11

Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children

Phase: N/A Priority: Normal
NCT ID: NCT01858740 Org: User:
Start: 04/10/14 End: 07/30/23 Due: 07/30/24

Carbohydrates and Related Biomarkers

Phase: N/A Priority: Normal
NCT ID: NCT00622661 Org: User:
Start: 06/30/06 End: 07/31/10 Due: 07/31/11

Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01758458 Org: User:
Start: 02/28/13 End: 05/31/16 Due: 05/31/17

Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00343785 Org: User:
Start: 02/28/06 End: 08/31/12 Due: 08/31/13

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis

Phase: N/A Priority: Normal
NCT ID: NCT00006367 Org: User:
Start: 05/31/00 End: 01/31/04 Due: 01/31/05

Women's Health Initiative Strong and Healthy Study

Phase: N/A Priority: Normal
NCT ID: NCT02425345 Org: User:
Start: 04/02/15 End: 12/31/24 Due: 12/31/25

Vaccine Responsiveness After CAR-T Cell Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04410900 Org: User:
Start: 08/03/20 End: 08/31/25 Due: 08/31/26

Rituximab Hyaluronidase in Combination With Chemotherapy in Treating Aggressive B-cell Lymphoma in Uganda

Phase: N/A Priority: Normal
NCT ID: NCT03864419 Org: User:
Start: 10/24/19 End: 07/26/23 Due: 07/26/24

Communication Strategy to PROMOTE HPV Vaccination in Pharmacies: PROMOTE Study

Phase: N/A Priority: Normal
NCT ID: NCT04660331 Org: User:
Start: 02/01/21 End: 07/31/23 Due: 07/31/24

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT03970096 Org: User:
Start: 11/19/19 End: 12/31/28 Due: 12/31/29

Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00016081 Org: User:
Start: 03/31/98 End: 03/31/03 Due: 03/31/04

HSV529 Vaccine in HSV-2 Seropositive Adults

Phase: N/A Priority: Normal
NCT ID: NCT02571166 Org: User:
Start: 11/30/15 End: 12/01/18 Due: 12/01/19

Cooking for Your Health in Southern New Mexico: an 8-week, Bilingual (English and Spanish) Nutritional Intervention in Adults Living in Doña Ana and Otero Counties

Phase: N/A Priority: Normal
NCT ID: NCT06609057 Org: User:
Start: 10/12/24 End: 04/07/25 Due: 04/07/26

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

Phase: N/A Priority: Normal
NCT ID: NCT03051516 Org: User:
Start: 08/01/17 End: 12/31/22 Due: 12/31/23

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Phase: N/A Priority: Normal
NCT ID: NCT00010283 Org: User:
Start: 07/31/00 End: 07/31/02 Due: 07/31/03

Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT03781778 Org: User:
Start: 05/07/19 End: 10/01/20 Due: 10/01/21

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Phase: N/A Priority: Normal
NCT ID: NCT04083183 Org: User:
Start: 06/16/20 End: 01/09/28 Due: 01/09/29

Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04994808 Org: User:
Start: 08/11/23 End: 04/03/27 Due: 04/03/28

Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00322101 Org: User:
Start: 01/31/06 End: 10/31/14 Due: 10/31/15

Improving Engagement in HIV and Cancer Care in Zimbabwe

Phase: N/A Priority: Normal
NCT ID: NCT06934369 Org: User:
Start: 11/18/24 End: 12/01/28 Due: 12/01/29

Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005851 Org: User:
Start: 02/29/00 End: 09/27/18 Due: 09/27/19

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00003146 Org: User:
Start: 11/30/97 End: 06/30/01 Due: 06/30/02

Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV

Phase: N/A Priority: Normal
NCT ID: NCT04682301 Org: User:
Start: 02/05/21 End: 03/14/23 Due: 03/14/24